Generic placeholder image

Current Diabetes Reviews

Editor-in-Chief

ISSN (Print): 1573-3998
ISSN (Online): 1875-6417

Research Article

Assessment of Patient-reported Satisfaction and Metabolic Outcomes Following Initiation of the Second Generation of Flash Glucose Monitoring in Patients with Type 1 Diabetes

Author(s): Ayman Al Hayek*, Asirvatham Alwin Robert, Wael M. Alzahrani and Mohamed Abdulaziz Al Dawish

Volume 20, Issue 4, 2024

Published on: 20 September, 2023

Article ID: e100823219628 Pages: 8

DOI: 10.2174/1573399820666230810123504

Price: $65

Abstract

Background and Aims: This study aims to assess patient-reported satisfaction and metabolic outcomes following the initiation of the second generation of the Freestyle Libre 2 (FSL2) system in patients with type 1 diabetes (T1D).

Methods: This non-randomized single-arm observation study was conducted on 86 patients with T1D living in Saudi Arabia, who were asked to wear the FSL2 for 12 weeks. The demographic data were collected at baseline, while the continuous glucose monitoring (CGM) metrics were gathered, i.e., Glucose Variability (GV) (%), mean Time in Range (TIR), Time Above Range (TAR), Time Below Range (TBR), and average duration of hypoglycemic events were collected at baseline, 6th week and 12 weeks. Further, the Continuous Glucose Monitoring Satisfaction (CGM-SAT) was collected at the end of the follow-up.

Results: Compared to the 6th week, significant differences were observed in the low glucose events (p = 0.037), % TIR (p = 0.045), and % below 70 mg/dL (p = 0.047) at 12 weeks. Improvement was seen in the other glucometric variables, but no significant changes were evident (p > 0.05). On completion of the study period, the ambulatory glucose profile (AGP) metrics showed a 74.3 ± 5.01 (mg/dL) FSL2 hypoglycemia alarm threshold and a 213 ± 38.1 (mg/dL) hyperglycemia alarm threshold. A majority of the patients stated that CGM-SAT had benefits (mean score > 3.58), although they felt FSL2 had ‘additional benefits. With regard to the problems with the use of FSL2 majority of the patients stated that FSL2 has minimal discomfort.

Conclusion: Using second-generation FSL2 in patients with T1D is positively associated with patient- reported satisfaction and metabolic outcomes.

[1]
Al Hayek AA, Robert AA, Al Dawish MA. Effectiveness of the freestyle libre flash glucose monitoring system on diabetes distress among individuals with type 1 diabetes: A prospective study. Diabetes Ther 2020; 11(4): 927-37.
[http://dx.doi.org/10.1007/s13300-020-00793-2] [PMID: 32146691]
[2]
Abdulaziz Al Dawish M, Alwin Robert A, Braham R, et al. Diabetes mellitus in saudi arabia: A review of the recent literature. Curr Diabetes Rev 2016; 12(4): 359-68.
[http://dx.doi.org/10.2174/1573399811666150724095130] [PMID: 26206092]
[3]
The International Diabetes Federation’s (IDF’s). Diabetes Atlas Available from: https://diabetesatlas.org
[4]
Alaqeel AA. Pediatric diabetes in Saudi Arabia: Challenges and potential solutions. A review article. Int J Pediatr Adolesc Med 2019; 6(4): 125-30.
[http://dx.doi.org/10.1016/j.ijpam.2019.05.008] [PMID: 31890836]
[5]
International Diabetes Federation IDF_Atlas_8e_ppt_2018. 2017. Available from: https://www.scribd.com/presentation/395164890/IDF-Atlas-8e-Ppt-2018#
[6]
Robert AA, Al-Dawish A, Mujammami M, Dawish MAA. Type 1 diabetes mellitus in Saudi Arabia: A soaring epidemic. Int J Pediatr 2018; 2018: 1-9.
[http://dx.doi.org/10.1155/2018/9408370] [PMID: 29853923]
[7]
Ong WM, Chua SS, Ng CJ. Barriers and facilitators to self-monitoring of blood glucose in people with type 2 diabetes using insulin: A qualitative study. Patient Prefer Adherence 2014; 8: 237-46.
[PMID: 24627628]
[8]
Leelarathna L, Wilmot EG. Flash forward: A review of flash glucose monitoring. Diabet Med 2018; 35(4): 472-82.
[http://dx.doi.org/10.1111/dme.13584] [PMID: 29356072]
[9]
Al Hayek AA, Robert AA, Al Dawish MA. Differences of freestyle libre flash glucose monitoring system and finger pricks on clinical characteristics and glucose monitoring satisfactions in type 1 diabetes using insulin pump. Clin Med Insights Endocrinol Diabetes 2019; 12: 1179551419861102.
[http://dx.doi.org/10.1177/1179551419861102] [PMID: 31308786]
[10]
Al Hayek AA, Robert AA, Al Dawish MA. Acceptability of the freestyle libre flash glucose monitoring system: The experience of young patients with type 1 diabetes. Clin Med Insights Endocrinol Diabetes 2020; 13: 1179551420910122.
[http://dx.doi.org/10.1177/1179551420910122] [PMID: 32206014]
[11]
Miller E, Midyett LK. Just because you can, doesn’t mean you should … Now. A practical approach to counseling persons with diabetes on use of optional CGM alarms. Diabetes Technol Ther 2021; 23(S3): S-66-71.
[http://dx.doi.org/10.1089/dia.2021.0192] [PMID: 34546081]
[12]
Bonora B, Maran A, Ciciliot S, Avogaro A, Fadini GP. Head-to-head comparison between flash and continuous glucose monitoring systems in outpatients with type 1 diabetes. J Endocrinol Invest 2016; 39(12): 1391-9.
[http://dx.doi.org/10.1007/s40618-016-0495-8] [PMID: 27287421]
[13]
Edge J, Acerini C, Campbell F, et al. An alternative sensor-based method for glucose monitoring in children and young people with diabetes. Arch Dis Child 2017; 102(6): 543-9.
[http://dx.doi.org/10.1136/archdischild-2016-311530] [PMID: 28137708]
[14]
Slattery D, Choudhary P. Clinical use of continuous glucose monitoring in adults with type 1 diabetes. Diabetes Technol Ther 2017; 19(S2): S-55-61.
[http://dx.doi.org/10.1089/dia.2017.0051] [PMID: 28541131]
[15]
Al-Harbi MY, Albunyan A, Alnahari A, et al. Frequency of flash glucose monitoring and glucose metrics: Real-world observational data from Saudi Arabia. Diabetol Metab Syndr 2022; 14(1): 66.
[http://dx.doi.org/10.1186/s13098-022-00831-y] [PMID: 35501880]
[16]
Alharbi MY, Albunyan A, Al Nahari A, et al. Measuring the impact of flash glucose monitoring in a pediatric population in saudi arabia: A retrospective cohort study. Diabetes Ther 2022; 13(6): 1139-46.
[http://dx.doi.org/10.1007/s13300-022-01224-0] [PMID: 35441933]
[17]
Oyagüez I, Merino-Torres JF. Cost analysis of the flash monitoring system (FreeStyle Libre 2) in adults with type 1 diabetes mellitus. BMJ Open Diabetes Res Care 2020; 8(1): e001330.
[18]
Bahíllo-Curieses MP, Díaz-Soto G, Vidueira-Martínez AM, Torres-Ballester I, Gómez-Hoyos E, de Luis-Román D. Assessment of metabolic control and use of flash glucose monitoring systems in a cohort of pediatric, adolescents, and adults patients with Type 1 diabetes. Endocrine 2021; 73(1): 47-51.
[http://dx.doi.org/10.1007/s12020-021-02691-4] [PMID: 33754313]
[19]
Saisho Y. Use of diabetes treatment satisfaction questionnaire in diabetes care: Importance of patient-reported outcomes. Int J Environ Res Public Health 2018; 15(5): 947.
[http://dx.doi.org/10.3390/ijerph15050947] [PMID: 29747423]
[20]
Duarte DB, Fonseca L, Santos T, et al. Impact of intermittently scanned continuous glucose monitoring on quality of life and glycaemic control in persons with type 1 diabetes: A 12-month follow-up study in real life. Diabetes Metab Syndr 2022; 16(6): 102509.
[http://dx.doi.org/10.1016/j.dsx.2022.102509] [PMID: 35598543]
[21]
Franceschi R, Scotton C, Leonardi L, et al. Impact of intermittently scanned continuous glucose monitoring with alarms on sleep and metabolic outcomes in children and adolescents with type 1 diabetes. Acta Diabetol 2022; 59(7): 911-9.
[http://dx.doi.org/10.1007/s00592-022-01882-3] [PMID: 35397650]
[22]
Boscari F, Ferretto S, Cavallin F, Fadini GP, Avogaro A, Bruttomesso D. Effectiveness of adding alarms to flash glucose monitoring in adults with type 1 diabetes under routine care. Acta Diabetol 2022; 59(7): 921-8.
[http://dx.doi.org/10.1007/s00592-022-01884-1]
[23]
Deeb A, Yousef H, Al Qahtani N, et al. Novel ambulatory glucose-sensing technology improves hypoglycemia detection and patient monitoring adherence in children and adolescents with type 1 diabetes. J Diabetes Metab Disord 2019; 18(1): 1-6.
[http://dx.doi.org/10.1007/s40200-018-0351-9] [PMID: 31275868]
[24]
Al Hayek AA, Robert AA, Al Dawish MA. Effectiveness of the freestyle libre 2 flash glucose monitoring system on diabetes-self-management practices and glycemic parameters among patients with type 1 diabetes using insulin pump. Diabetes Metab Syndr 2021; 15(5): 102265.
[http://dx.doi.org/10.1016/j.dsx.2021.102265] [PMID: 34488057]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy